{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:01:43Z","timestamp":1787065303814,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10822-015-9848-1","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T05:19:29Z","timestamp":1431062369000},"page":"561-581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Combining docking-based comparative intermolecular contacts analysis and k-nearest neighbor correlation for the discovery of new check point kinase 1 inhibitors"],"prefix":"10.1007","volume":"29","author":[{"given":"Nour Jamal","family":"Jaradat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Khanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Habash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutasem Omar","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"key":"9848_CR1","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.4161\/cc.10.13.16398","volume":"10","author":"L Carrassa","year":"2011","unstructured":"Carrassa L, Damia G (2011) Unleashing Chk1 in cancer therapy. Cell Cycle 10:2121\u20132128. doi: 10.4161\/cc.10.13.16398","journal-title":"Cell Cycle"},{"key":"9848_CR2","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1021\/jm048989d","volume":"48","author":"GT Wang","year":"2005","unstructured":"Wang GT, Li G, Mantei RA, Chen Z, Kovar P, Gu W, Xiao Z, Zhang H, Sham HL, Sowin T, Rosenberg SH, Lin NH (2005) 1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyanopyrazin-2-yl)ureas [correction of cyanopyrazi] as potent and selective inhibitors of Chk1 kinase: synthesis, preliminary SAR, and biological activities. J Med Chem 48:3118\u20133121. doi: 10.1021\/jm048989d","journal-title":"J Med Chem"},{"key":"9848_CR3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrc1296","volume":"4","author":"BB Zhou","year":"2004","unstructured":"Zhou BB, Bartek J (2004) Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat Rev Cancer 4:216\u2013225. doi: 10.1038\/nrc1296","journal-title":"Nat Rev Cancer"},{"key":"9848_CR4","first-page":"5843","volume":"61","author":"Y Hirose","year":"2001","unstructured":"Hirose Y, Berger MS, Pieper RO (2001) Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Cancer Res 61:5843\u20135849","journal-title":"Cancer Res"},{"key":"9848_CR5","first-page":"1643","volume":"55","author":"SN Powell","year":"1995","unstructured":"Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, Friend S (1995) Differential sensitivity of p53(\u2212) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 55:1643\u20131648","journal-title":"Cancer Res"},{"key":"9848_CR6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1535-7163.513.3.4","volume":"3","author":"T Kawabe","year":"2004","unstructured":"Kawabe T (2004) G2 checkpoint abrogators as anticancer drugs. Mol Cancer Ther 3:513\u2013519","journal-title":"Mol Cancer Ther"},{"key":"9848_CR7","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1038\/sj.onc.1204942","volume":"20","author":"K Koniaras","year":"2001","unstructured":"Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, O\u2019Connell MJ (2001) Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene 20:7453\u20137463. doi: 10.1038\/sj.onc.1204942","journal-title":"Oncogene"},{"key":"9848_CR8","first-page":"2483","volume":"62","author":"H Wang","year":"2002","unstructured":"Wang H, Wang X, Zhou XY, Chen DJ, Li GC, Iliakis G, Wang Y (2002) Ku affects the ataxia and Rad 3-related\/CHK1-dependent S phase checkpoint response after camptothecin treatment. Cancer Res 62:2483\u20132487","journal-title":"Cancer Res"},{"issue":"6","key":"9848_CR9","first-page":"543","volume":"2","author":"Z Chen","year":"2003","unstructured":"Chen Z, Xiao Z, Chen J, Ng SC, Sowin T, Sham H, Rosenberg S, Fesik S, Zhang H (2003) Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint. Mol Cancer Ther 2(6):543\u2013548","journal-title":"Mol Cancer Ther"},{"key":"9848_CR10","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1074\/jbc.275.8.5600","volume":"275","author":"PR Graves","year":"2000","unstructured":"Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O\u2019Connor PM, Piwnica-Worms H (2000) The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 275:5600\u20135605. doi: 10.1074\/jbc.275.8.5600","journal-title":"J Biol Chem"},{"key":"9848_CR11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1021\/ci100368t","volume":"51","author":"MO Taha","year":"2011","unstructured":"Taha MO, Habash M, Al-Hadidi Z, Al-Bakri A, Younis K, Sisan S (2011) Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies. J Chem Inf Model 51:647\u2013669. doi: 10.1021\/ci100368t","journal-title":"J Chem Inf Model"},{"key":"9848_CR12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10822-014-9740-4","volume":"28","author":"MO Taha","year":"2014","unstructured":"Taha MO, Habash M, Khanfar MA (2014) The use of docking-based comparative intermolecular contacts analysis to identify optimal docking conditions within glucokinase and to discover of new GK activators. J Comput Aided Mol Des 28:509\u2013547. doi: 10.1007\/s10822-014-9740-4","journal-title":"J Comput Aided Mol Des"},{"key":"9848_CR13","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1007\/s00894-012-1479-z","volume":"18","author":"MA Al-Sha\u2019er","year":"2012","unstructured":"Al-Sha\u2019er MA, Taha MO (2012) Application of docking-based comparative intermolecular contacts analysis to validate Hsp90alpha docking studies and subsequent in silico screening for inhibitors. J Mol Model 18:4843\u20134863. doi: 10.1007\/s00894-012-1479-z","journal-title":"J Mol Model"},{"key":"9848_CR14","volume-title":"Chemometrics","author":"MA Sharaf","year":"1986","unstructured":"Sharaf MA, Illman DL, Kowalski BR (1986) Chemometrics. Wiley, New York"},{"key":"9848_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/ci980033m","volume":"40","author":"W Zheng","year":"2000","unstructured":"Zheng W, Tropsha A (2000) Novel variable selection quantitative structure\u2014property relationship approach based on the k-nearest-neighbor principle. J Chem Inf Comput Sci 40:185\u2013194. doi: 10.1021\/ci980033m","journal-title":"J Chem Inf Comput Sci"},{"issue":"10","key":"9848_CR16","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ci4003798","volume":"53","author":"MA Khanfar","year":"2013","unstructured":"Khanfar MA, Taha MO (2013) Elaborate ligand-based modeling coupled with multiple linear regression and k nearest neighbor QSAR analyses unveiled new nanomolar mTOR inhibitors. J Chem Inf Model 53(10):2587\u20132612. doi: 10.1021\/ci4003798","journal-title":"J Chem Inf Model"},{"issue":"23","key":"9848_CR17","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1016\/j.bmcl.2007.09.063","volume":"17","author":"ZF Tao","year":"2007","unstructured":"Tao ZF, Chen Z, Bui MH, Kovar P, Johnson E, Bouska J, Zhang H, Rosenberg S, Sowin T, Lin NH (2007) Macrocyclic ureas as potent and selective Chk1 inhibitors: an improved synthesis, kinome profiling, structure-activity relationships, and preliminary pharmacokinetics. Bioorg Med Chem Lett 17(23):6593\u20136601. doi: 10.1016\/j.bmcl.2007.09.063","journal-title":"Bioorg Med Chem Lett"},{"issue":"21","key":"9848_CR18","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1016\/j.bmcl.2007.07.102","volume":"17","author":"ZF Tao","year":"2007","unstructured":"Tao ZF, Li G, Tong Y, Stewart KD, Chen Z, Bui MH, Merta P, Park C, Kovar P, Zhang H, Sham HL, Rosenberg SH, Sowin TJ, Lin NH (2007) Discovery of 4\u2032-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4\u2032-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2\u2032-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors. Bioorg Med Chem Lett 17(21):5944\u20135951. doi: 10.1016\/j.bmcl.2007.07.102","journal-title":"Bioorg Med Chem Lett"},{"issue":"15","key":"9848_CR19","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1016\/j.bmcl.2007.05.027","volume":"17","author":"ZF Tao","year":"2007","unstructured":"Tao ZF, Li G, Tong Y, Chen Z, Merta P, Kovar P, Zhang H, Rosenberg SH, Sham HL, Sowin TJ, Lin NH (2007) Synthesis and biological evaluation of 4\u2032-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors. Bioorg Med Chem Lett 17(15):4308\u20134315. doi: 10.1016\/j.bmcl.2007.05.027","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"9848_CR20","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1021\/jm061247v","volume":"50","author":"ZF Tao","year":"2007","unstructured":"Tao ZF, Wang L, Stewart KD, Chen Z, Gu W, Bui MH, Merta P, Zhang H, Kovar P, Johnson E, Park C, Judge R, Rosenberg S, Sowin T, Lin NH (2007) Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors. J Med Chem 50(7):1514\u20131527. doi: 10.1021\/jm061247v","journal-title":"J Med Chem"},{"key":"9848_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1093-3263(02)00164-X","volume":"21","author":"CM Venkatachalam","year":"2003","unstructured":"Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003) LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model 21:289\u2013307. doi: 10.1016\/S1093-3263(02)00164-X","journal-title":"J Mol Graph Model"},{"issue":"4","key":"9848_CR22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/ci00020a020","volume":"34","author":"D Rogers","year":"1994","unstructured":"Rogers D, Hopfinger AJ (1994) Application of genetic function approximation to quantitative structure-Activity-relationships and quantitative structure-property relationships. J Chem Inf Comput Sci 34(4):854\u2013866. doi: 10.1021\/Ci00020a020","journal-title":"J Chem Inf Comput Sci"},{"issue":"3","key":"9848_CR23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/ci034289q","volume":"44","author":"ML Verdonk","year":"2004","unstructured":"Verdonk ML, Berdini V, Hartshorn MJ, Mooij WT, Murray CW, Taylor RD, Watson P (2004) Virtual screening using protein-ligand docking: avoiding artificial enrichment. J Chem Inf Comput Sci 44(3):793\u2013806. doi: 10.1021\/ci034289q","journal-title":"J Chem Inf Comput Sci"},{"issue":"2","key":"9848_CR24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jmgm.2007.02.002","volume":"26","author":"AM Abu Hammad","year":"2007","unstructured":"Abu Hammad AM, Afifi FU, Taha MO (2007) Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions. J Mol Graph Model 26(2):443\u2013456. doi: 10.1016\/j.jmgm.2007.02.002","journal-title":"J Mol Graph Model"},{"issue":"6","key":"9848_CR25","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.ejmech.2009.01.031","volume":"44","author":"A Abu-Hammad","year":"2009","unstructured":"Abu-Hammad A, Zalloum WA, Zalloum H, Abu-Sheikha G, Taha MO (2009) Homology modeling of MCH1 receptor and validation by docking\/scoring and protein-aligned CoMFA. Eur J Med Chem 44(6):2583\u20132596. doi: 10.1016\/j.ejmech.2009.01.031","journal-title":"Eur J Med Chem"},{"issue":"25","key":"9848_CR26","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1021\/jm058047o","volume":"48","author":"MO Taha","year":"2005","unstructured":"Taha MO, AlDamen MA (2005) Effects of variable docking conditions and scoring functions on corresponding protein-aligned comparative molecular field analysis models constructed from diverse human protein tyrosine phosphatase 1B inhibitors. J Med Chem 48(25):8016\u20138034. doi: 10.1021\/jm058047o","journal-title":"J Med Chem"},{"issue":"13\u201314","key":"9848_CR27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.drudis.2007.05.004","volume":"12","author":"SW Homans","year":"2007","unstructured":"Homans SW (2007) Water, water everywhere\u2013except where it matters? Drug Discov Today 12(13\u201314):534\u2013539. doi: 10.1016\/j.drudis.2007.05.004","journal-title":"Drug Discov Today"},{"issue":"5","key":"9848_CR28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/bib\/bbp023","volume":"10","author":"CM Song","year":"2009","unstructured":"Song CM, Lim SJ, Tong JC (2009) Recent advances in computer-aided drug design. Brief Bioinform 10(5):579\u2013591. doi: 10.1093\/bib\/bbp023","journal-title":"Brief Bioinform"},{"issue":"6","key":"9848_CR29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/ar800236t","volume":"42","author":"WL Jorgensen","year":"2009","unstructured":"Jorgensen WL (2009) Efficient drug lead discovery and optimization. Acc Chem Res 42(6):724\u2013733. doi: 10.1021\/ar800236t","journal-title":"Acc Chem Res"},{"issue":"20","key":"9848_CR30","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1021\/jm060999m","volume":"49","author":"AR Leach","year":"2006","unstructured":"Leach AR, Shoichet BK, Peishoff CE (2006) Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. J Med Chem 49(20):5851\u20135855. doi: 10.1021\/jm060999m","journal-title":"J Med Chem"},{"issue":"1","key":"9848_CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcc.21303","volume":"31","author":"E Krissinel","year":"2010","unstructured":"Krissinel E (2010) Crystal contacts as nature\u2019s docking solutions. J Comput Chem 31(1):133\u2013143. doi: 10.1002\/jcc.21303","journal-title":"J Comput Chem"},{"issue":"12","key":"9848_CR32","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.bmcl.2006.03.059","volume":"16","author":"ZJ Ni","year":"2006","unstructured":"Ni ZJ, Barsanti P, Brammeier N, Diebes A, Poon DJ, Ng S, Pecchi S, Pfister K, Renhowe PA, Ramurthy S, Wagman AS, Bussiere DE, Le V, Zhou Y, Jansen JM, Ma S, Gesner TG (2006) 4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors. Bioorg Med Chem Lett 16(12):3121\u20133124. doi: 10.1016\/j.bmcl.2006.03.059","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"9848_CR33","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1021\/jm049022c","volume":"48","author":"N Foloppe","year":"2005","unstructured":"Foloppe N, Fisher LM, Howes R, Kierstan P, Potter A, Robertson AG, Surgenor AE (2005) Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity. J Med Chem 48(13):4332\u20134345. doi: 10.1021\/jm049022c","journal-title":"J Med Chem"},{"key":"9848_CR34","first-page":"325","volume-title":"Langer T","author":"N Triballeau","year":"2006","unstructured":"Triballeau N, Bertrand H-O, Acher F (2006) Are you sure you have a good model? In: Hoffmann RD (ed) Langer T. Pharmacophores and Pharmacophore Searches, Wiley, pp 325\u2013364"},{"issue":"1\u20133","key":"9848_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326. doi: 10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"9848_CR36","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45(12):2615\u20132623. doi: 10.1021\/jm020017n","journal-title":"J Med Chem"},{"issue":"24","key":"9848_CR37","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1021\/jm2007326","volume":"54","author":"JC Reader","year":"2011","unstructured":"Reader JC, Matthews TP, Klair S, Cheung KM, Scanlon J, Proisy N, Addison G, Ellard J, Piton N, Taylor S, Cherry M, Fisher M, Boxall K, Burns S, Walton MI, Westwood IM, Hayes A, Eve P, Valenti M, de Haven Brandon A, Box G, van Montfort RL, Williams DH, Aherne GW, Raynaud FI, Eccles SA, Garrett MD, Collins I (2011) Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing. J Med Chem 54(24):8328\u20138342. doi: 10.1021\/jm2007326","journal-title":"J Med Chem"},{"issue":"7","key":"9848_CR38","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I, Pin JP, Bertrand HO (2005) Virtual screening workflow development guided by the \u201creceiver operating characteristic\u201d curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 48(7):2534\u20132547. doi: 10.1021\/jm049092j","journal-title":"J Med Chem"},{"issue":"3\u20134","key":"9848_CR39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10822-007-9163-6","volume":"22","author":"J Kirchmair","year":"2008","unstructured":"Kirchmair J, Markt P, Distinto S, Wolber G, Langer T (2008) Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection\u2013what can we learn from earlier mistakes? J Comput Aided Mol Des 22(3\u20134):213\u2013228. doi: 10.1007\/s10822-007-9163-6","journal-title":"J Comput Aided Mol Des"},{"issue":"7","key":"9848_CR40","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.bmcl.2012.01.110","volume":"22","author":"VY Dudkin","year":"2012","unstructured":"Dudkin VY, Rickert K, Kreatsoulas C, Wang C, Arrington KL, Fraley ME, Hartman GD, Yan Y, Ikuta M, Stirdivant SM, Drakas RA, Walsh ES, Hamilton K, Buser CA, Lobell RB, Sepp-Lorenzino L (2012) Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates. Bioorg Med Chem Lett 22(7):2609\u20132612. doi: 10.1016\/j.bmcl.2012.01.110","journal-title":"Bioorg Med Chem Lett"},{"key":"9848_CR41","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejmech.2014.07.056","volume":"84","author":"MO Taha","year":"2014","unstructured":"Taha MO, Al-Sha\u2019er MA, Khanfar MA, Al-Nadaf AH (2014) Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. Eur J Med Chem 84:454\u2013465. doi: 10.1016\/j.ejmech.2014.07.056","journal-title":"Eur J Med Chem"},{"issue":"1","key":"9848_CR42","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1007\/s00894-014-2080-4","volume":"20","author":"MA Al-Sha\u2019er","year":"2014","unstructured":"Al-Sha\u2019er MA, Khanfar MA, Taha MO (2014) Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. J Mol Model 20(1):2080. doi: 10.1007\/s00894-014-2080-4","journal-title":"J Mol Model"},{"issue":"12","key":"9848_CR43","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10822-013-9699-6","volume":"27","author":"S Abuhamdah","year":"2013","unstructured":"Abuhamdah S, Habash M, Taha MO (2013) Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors. J Comput Aided Mol Des 27(12):1075\u20131092. doi: 10.1007\/s10822-013-9699-6","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"9848_CR44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17460441.2013.788496","volume":"8","author":"TP Matthews","year":"2013","unstructured":"Matthews TP, Jones AM, Collins I (2013) Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies. Expert Opin Drug Discov 8(6):621\u2013640. doi: 10.1517\/17460441.2013.788496","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"9848_CR45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/adt.2007.073","volume":"5","author":"P-E Imbert","year":"2007","unstructured":"Imbert P-E, Unterreiner V, Siebert D, Gubler H, Parker C, Gabriel D (2007) Recommendations for the reduction of compound artifacts in time-resolved fluorescence resonance energy transfer assays. Assay Drug Dev Technol 5(3):363\u2013372. doi: 10.1089\/adt.2007.073","journal-title":"Assay Drug Dev Technol"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-015-9848-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9848-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T02:40:44Z","timestamp":1691635244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-015-9848-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["9848"],"URL":"https:\/\/doi.org\/10.1007\/s10822-015-9848-1","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]}}}